Home
Reels
Gruplar
Sayfalar
Daha fazla gör
Gruplar Sayfalar Events Blogs Offers Jobs Courses Forums Movies Oyunlar
Giriş yapın Başvur
Night Mode
Why Monoclonal Antibodies Lead the Oncology Biosimilars Market
Monoclonal antibodies have transformed cancer treatment by targeting specific proteins and pathways involved in tumor growth or immune regulation. As the patents of major biologic medicines expire, biosimilar versions are creating new competition in oncology. The Oncology Biosimilars Market is forecast to grow from USD 5.469 billion in 2024 to USD 14.4 billion by 2035. Monoclonal antibodies...
0 Yorumlar ·0 SGT senetleri ·226 Views ·0 önizleme
Please log in to like, share and comment!